Healthcare - Biotechnology - NASDAQ - BM
$ 0.4554
5.91 %
$ 1.72 M
Market Cap
0.25
P/E
CASH FLOW STATEMENT
-11.5 M
OPERATING CASH FLOW
1.44 M
INVESTING CASH FLOW
10.6 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Altamira Therapeutics Ltd.
| Net Income | -3.87 M |
| Depreciation & Amortization | 119 K |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 0 |
| Change in Working Capital | -4.24 M |
| Others | -7.34 M |
| Free Cash Flow | -11.5 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (3.9) | (26.5) | (17.4) | (8.2) | (6.6) | (11.5) | (24.4) | (30.7) | (29.7) | (18.2) | (15.0) | (4.6) |
| Depreciation & Amortization | 0.1 | 0.1 | 76.4 K | 20 K | 30.8 K | 72.7 K | 0.1 | 97.6 K | 92.8 K | 74 K | 37.5 K | 9.24 K |
| Deferred Income Tax | 99.8 K | 10.3 K | 21.6 K | 21.3 K | (0.2) | 0.2 | 17.8 K | (0.1) | (1.1) | (4.1) | 0.3 | 30.5 K |
| Stock Based Compensation | 0 | 0.3 | 1.2 | 0.4 | 0.2 | 27.7 K | 0.4 | 0.3 | 0.3 | 0.3 | 0.1 | 56 K |
| Other Operating Activities | (3.4) | 13.8 | 1.9 | 2.7 | (0.6) | 0.5 | 0.1 | 0.7 | 36.4 K | 2.5 K | 36.2 K | 5.82 K |
| Change in Working Capital | (4.2) | 3.6 | 0.5 | 0.3 | (1.2) | (2.5) | (0.5) | 0.3 | 1.7 | 2.6 | 0.5 | 14 K |
| Cash From Operations | (11.5) | (8.7) | (13.7) | (4.8) | (8.4) | (13.2) | (24.3) | (29.5) | (28.7) | (19.3) | (14.0) | (4.5) |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | 0 | (2.1) | (3.3) | (2.3) | (3.0) | (1.9) | (0.2) | (0.2) | 79.9 K | (1.2) | (0.1) | (0.1) |
| Other Items | 1.4 | 969 | (0.2) | 258 | 17.9 K | 68.2 K | 53.6 K | 67.6 K | 36.6 K | 52.1 K | 74 K | 78.7 K |
| Cash From Investing Activities | 1.4 | (2.1) | (3.5) | (2.3) | (3.0) | (1.8) | 99.4 K | (0.2) | 43.4 K | (1.2) | 34.9 K | 53.1 K |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 1.0 | 5.9 | 68.7 K | 1.5 | (1.5) | (9.3) | (2.1) | 12.0 | 0 | 0 | 13.8 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 9.6 | 3.9 | 6.7 | 15.4 | (1.0) | (2.4) | (2.7) | (0.5) | (0.2) | (0.4) | 9.92 K | 0 |
| Cash From Financing Activities | 10.6 | 9.8 | 6.6 | 17.0 | 7.4 | 5.7 | 8.2 | 11.4 | 20.9 | 49.6 | 37.9 | 3.9 |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | 0.6 | (1.0) | (10.3) | 9.9 | (4.0) | (9.6) | (17.5) | (17.8) | (6.7) | 33.1 | 23.8 | (0.7) |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | (11.5) | (10.8) | (17.0) | (7.2) | (11.4) | (15.1) | (24.4) | (29.7) | (28.8) | (20.6) | (14.2) | (4.6) |